US$ 22.13
types of glp 1 receptor agonists Classification currently available glucagon-like peptide-1 Association of glucagon-like peptide-1 receptor
Description
Patients should not independently stop therapy without discussing the plan with their care team, because abrupt interruption may affect glucose control or other treatment goals

Treatment with GLP-1RA downregulates NF-B activation in hepatic tissue, thereby leading to decreased transcription of cytokines and chemokines that sustain inflammation (23, 24)

(iii) Is the current contraceptive method reliable and sustainable throughout the treatment period
Although is there much benefit for monthly dosing over weekly
